Latest News and Press Releases
Want to stay updated on the latest news?
-
FREMONT, Calif., Sept. 9, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (Nasdaq:WGBS) will present results from the Company's single-cell analysis system at the Single Cell Genomics (SCG)...
-
BEIJING and FREMONT, Calif., Aug. 17, 2015 (GLOBE NEWSWIRE) -- Annoroad has selected the WaferGen Bio-systems, Inc. (Nasdaq:WGBS) SmartChip platform for high-throughput target enrichment of BRCA1 and...
-
Company Continues to Advance Single Cell Analysis Technology According to Plan; Full Commercial Launch on Track for Fourth Quarter of 2015 Early Access Program for WaferGen's Single Cell Analysis...
-
FREMONT, Calif., July 27, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (NASDAQ:WGBS) announced today that it will announce second quarter ended June 30, 2015 financial results after the market...
-
FREMONT, Calif., May 5, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (Nasdaq:WGBS) announced today that it will announce first quarter ended March 31, 2015 financial results after the market...
-
FREMONT, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (Nasdaq:WGBS) announced today that the Company has signed a research collaboration with Genentech, a member of the Roche...
-
FREMONT, Calif., April 13, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (Nasdaq:WGBS) announced today that it will host a KOL Webinar on the topic of "Clinical NGS Testing Strategies for...
-
FREMONT, Calif., March 26, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (Nasdaq:WGBS) announced today an important industrial partnership with Procter & Gamble whereby Procter & Gamble...
-
FREMONT, Calif., March 4, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, (Nasdaq:WGBS) announced today that will announce fourth quarter and fiscal year 2014 financial results after the market close...
-
FREMONT, Calif., Feb. 25, 2015 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, (Nasdaq:WGBS) announced today that it has produced positive results in a study aimed at validating the utility of its...